Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 14, 2025 10:00 ET | Source: Angelini Ventures

Angelini Ventures Invests into $39 Million Series A Extension Round for Therini Bio, a Clinical Stage Company Developing Fibrin-targeting Immunotherapies for Neurodegenerative Diseases

Angelini Ventures joins top-tier investor syndicate Investment will fund Phase 1b studies evaluating Therini Bio’s lead candidate, THN391, for the treatment of Alzheimer’s Disease (AD) and Diabetic...
May 06, 2025 02:00 ET | Source: Angelini Ventures

Angelini Ventures Co-Leads $45 Million Series B Financing of Nuevocor to Advance Transformative Treatment for Genetic Dilated Cardiomyopathy

Angelini Ventures marks its first investment in the cardiovascular and gene therapy space – and first in Asia, further diversifying its strong and growing portfolio Rome, Italy - 6 May 2025 –...
April 07, 2025 02:00 ET | Source: Angelini Ventures

Angelini Ventures Appoints Seasoned Life Sciences Investor, Dr. Regina Hodits, as Managing Director

Accomplished biotech investor with a track record of successful company-building and exits to lead Angelini Ventures’ international BioTech investment strategy Rome, Italy, 7 April 2025 – Angelini...
March 12, 2025 03:30 ET | Source: Angelini Ventures

Angelini Ventures leads €10 million Series A financing in Vantis, a Digital Care Innovation company

Strategic investment in digital health solutions addressing critical challenges in primary care and chronic disease management Rome, Italy, 12 March 2025 – Angelini Ventures, the corporate venture...
January 28, 2025 01:05 ET | Source: Angelini Ventures

Angelini Ventures co-leads €35 million oversubscribed Series B financing in Nobi, an AgeTech company, to expand AI-enabled technology across senior care facilities globally

Angelini Ventures’ investment in Nobi demonstrates its continued strategic focus on digital health and connected health devices and represents a significant opportunity to improve the wellbeing of...
January 08, 2025 02:00 ET | Source: Angelini Ventures

Angelini Ventures co-leads €20 million Series A financing in Neumirna Therapeutics to Develop Next-Generation RNA Therapeutics for Epilepsy and other Neurological Disorders

Angelini Ventures co-leads alongside Invivo Partners with participation from Innovestor’s Life Science Fund and other existing investors Financing will support clinical development of Neumirna‘s...
March 21, 2024 03:00 ET | Source: Angelini Ventures

Angelini Ventures invests into extended €75.8 million ($82 million) Series C financing round for Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized cancer vaccines

Angelini Ventures joins syndicate of top-tier international healthcare investors in Nouscom’s Series C financing roundFinancing will enable Nouscom to continue advancing the clinical development of...